Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Bisabolol, a natural monocyclic sesquiterpene alcohol primarily obtained from chamomile (Matricaria recutita), is recognized for its anti-inflammatory, antimicrobial, and soothing properties. Regarding its use in supporting or treating colds, particularly via antiviral effects, the evidence is limited but not absent. Preclinical studies have indicated that bisabolol exhibits some antiviral activity, although most research has focused on its antibacterial and anti-inflammatory actions. In vitro experiments have demonstrated inhibitory effects on certain viruses, but these findings are not robustly replicated in human studies or large-scale clinical trials.

Traditional use of chamomile preparations for colds and respiratory ailments is well documented, and bisabolol is one of the active constituents thought to contribute to these effects. The proposed mechanisms include modulation of cytokine production and mild inhibition of viral replication, likely secondary to its anti-inflammatory actions. However, the direct antiviral activity of bisabolol against common cold viruses (e.g., rhinoviruses, coronaviruses) has not been conclusively established. Most scientific validation comes from animal models or cell cultures, with a lack of high-quality human clinical data specifically targeting cold viruses.

Overall, while there is some scientific rationale and preliminary laboratory evidence suggesting bisabolol may offer supportive benefits during colds (largely through anti-inflammatory and possibly mild antiviral effects), the evidence remains weak (rated 2/5), and more rigorous clinical research is needed to confirm its efficacy for this indication.

More about bisabolol
More about Colds (antiviral)

Other ingredients used for Colds (antiviral)

Other health conditions supported by bisabolol

Products containing bisabolol